Terms: = Prostate cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Staging
4 results:
1. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
[TBL] [Abstract] [Full Text] [Related]
3. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis.
Zaman MU; Fatima N; Sajjad Z; Hashmi I; Khan K
Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858
[TBL] [Abstract] [Full Text] [Related]
4. Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging.
Lee SH; Park KK; Choi KH; Lim BJ; Kim JH; Lee SW; Chung BH
World J Urol; 2010 Dec; 28(6):667-72. PubMed ID: 20623288
[TBL] [Abstract] [Full Text] [Related]
